BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9308636)

  • 1. Suitability of preadmission blood samples for pretransfusion testing in elective surgery.
    Marosszeky S; McDonald S; Sutherland J; Haysom H; Haeusler M; Sellings C; Metz J; McGrath KM
    Transfusion; 1997 Sep; 37(9):910-2. PubMed ID: 9308636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ensuring timely completion of type and screen testing and the verification of ABO/Rh status for elective surgical patients.
    Saxena S; Nelson JM; Osby M; Shah M; Kempf R; Shulman IA
    Arch Pathol Lab Med; 2007 Apr; 131(4):576-81. PubMed ID: 17425387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type and screen completion for scheduled surgical procedures. A College of American Pathologists Q-Probes study of 8941 type and screen tests in 108 institutions.
    Friedberg RC; Jones BA; Walsh MK;
    Arch Pathol Lab Med; 2003 May; 127(5):533-40. PubMed ID: 12708894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of a liberal policy for extended-date preadmission testing samples.
    Le N; Harach ME; Gould JM; Herman JH
    Transfusion; 2014 Jul; 54(7):1769-72. PubMed ID: 24456011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and cost-containment data that advocate abbreviated pretransfusion testing.
    Cordle DG; Strauss RG; Snyder EL; Floss AM
    Am J Clin Pathol; 1990 Oct; 94(4):428-31. PubMed ID: 2220670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. North American pretransfusion testing practices, 2001-2004: results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004.
    Shulman IA; Maffei LM; Downes KA
    Arch Pathol Lab Med; 2005 Aug; 129(8):984-9. PubMed ID: 16048410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted?
    Judd WJ; Fullen DR; Steiner EA; Davenport RD; Knafl PC
    Transfusion; 1999 Mar; 39(3):295-9. PubMed ID: 10204593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete pretransfusion testing leads to surgical delays.
    McWilliams B; Yazer MH; Cramer J; Triulzi DJ; Waters JH
    Transfusion; 2012 Oct; 52(10):2139-44; quiz 2145. PubMed ID: 22348700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited.
    Judd WJ; Barnes BA; Steiner EA; Oberman HA; Averill DB; Butch SH
    Transfusion; 1986; 26(3):220-4. PubMed ID: 3705135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exponential error reduction in pretransfusion testing with automation.
    South SF; Casina TS; Li L
    Transfusion; 2012 Aug; 52(8):81S-87S. PubMed ID: 22882101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficiency in providing blood to surgical patients using a novel approach to preadmission testing.
    Jefferies LC; Smith ME; Strobl FJ; Traber KB
    Am J Med Qual; 2000; 15(6):251-6. PubMed ID: 11126594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the indirect antiglobulin crossmatch justified?
    Peterson DM; Roxby DJ; Seshadri R
    Pathology; 1987 Apr; 19(2):121-3. PubMed ID: 3502613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of the "group-and-screen" for the full crossmatch in elective operations.
    Kelton JG; Perrault RA; Blajchman MA
    Can Anaesth Soc J; 1983 Nov; 30(6):641-5. PubMed ID: 6640401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a data driven maximum surgical blood ordering schedule on preoperative blood ordering practices.
    Woodrum CL; Wisniewski M; Triulzi DJ; Waters JH; Alarcon LH; Yazer MH
    Hematology; 2017 Oct; 22(9):571-577. PubMed ID: 28441911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When should antibody screening tests be done for recently transfused patients?
    Shulman IA; Nelson JM; Nakayama R
    Transfusion; 1990 Jan; 30(1):39-41. PubMed ID: 2296788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic verification of donor-recipient compatibility: the computer crossmatch.
    Butch SH; Judd WJ; Steiner EA; Stoe M; Oberman HA
    Transfusion; 1994 Feb; 34(2):105-9. PubMed ID: 8310478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransfusion compatibility testing for red blood cell administration.
    Shulman IA; Downes KA; Sazama K; Maffei LM
    Curr Opin Hematol; 2001 Nov; 8(6):397-404. PubMed ID: 11604582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Novel Monoclonal Antibody Therapeutics on Blood Bank Pretransfusion Testing.
    Mei Z; Wool GD
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):797-811. PubMed ID: 31466605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.